Please see the information below that has been sent to us to share with our members, regarding a double-blind controlled trial of a new topical treatment for mild-moderate alopecia areata that has recently started in the UK. The trial is sponsored by a UK pharma company (Manentia). Members of The Institute of Trichologists have been […]
Clinical Trial for Alopecia Areata Read More »
We’ve all grown up hearing various old wives tales and mysterious and wondrous ways to cure all. However, how much truth is there really in some of these myths. Here, Consultant Trichologist and Manager of Education at The Institute of Trichologists, Sara Alkazraji MIT, explores and explains the truth behind many of the common hair
The Great Hair Myths Read More »
With the cost-of-living crisis appearing daily in the news, many are looking for ways to reduce their outgoings and seeking ways to cut back. Hair care is certainly an area that can bring with it additional costs such as regular visits to the hairdresser, colour appointments, the latest styling tool and product, but great hair
Haircare on a budget Read More »
The Institute of Trichologists’ Member Dr Michael Ryan collaborated in a study looking at adult stem cell released molecules in combination with microneedling restoring hair growth. Introduction: Alopecia is a chronic dermatological disorder affecting millions of people, in which people lose some or all of the hair on their head. Although alopecia has many forms,
PROFESSOR ANDREW MESSENGER MD FRCP A study on the epidemiology of alopecia areata in the UK has recently been published in the British Journal of Dermatology [1]. It is currently online only but due to appear in print in the near future in open access form. The investigators used a large primary care database containing
Alopecia Areata Epidemiology Read More »
PROFESSOR ANDREW MESSENGER MD FRCP There are an increasing number of case reports and small case series describing hair regrowth following treatment with the monoclonal antibody drug dupilumab. Dupilumab is licensed for treating atopic dermatitis and the original observations were serendipitous in patients who happened to have alopecia areata as well as dermatitis. Although there
Dupilumab in Alopecia Areata Read More »